Trademark Overview
On Thursday, April 16, 2026, a trademark application was filed for AIGENTBM with the United States Patent and Trademark Office. The USPTO has given the AIGENTBM trademark a serial number of 99767031. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 16, 2026. This trademark is owned by BMD BioTech Co., Ltd.. The AIGENTBM trademark is filed in the Pharmaceutical Products category with the following description:
Genetic identity tests comprised of reagents for medical purposes; Diagnostic preparations for medical purposes; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Protein arrays for medical diagnosis purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, sexually transmitted diseases; Reagents for medical use; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Cells for medical or clinical use; Enzyme preparations for medical purposes; Reagents and media for medical and veterinary diagnostic purposes; Diagnostic biomarker reagents for medical purposes; Specimen collection kits comprised primarily of swabs for medical purposes and also including collection, transportation, and preservation of nucleic acid samples mainly involve the collection, packaging, preservation, and transportation of pharyngeal swabs, nasal swabs, or...
